Bioxytran, Inc (BIXT) stock
BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.02−0.00 (-3.95%)
Close on Oct 19, 2026Market cap $2.56MP/E –Yield –
Bioxytran enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Bioxytran's enterprise value was $2.39M on Oct 19, 2026, against $6.16M a year earlier. Over the last 5 years it ranged from $753.89K to $61.71M, with a median of $14.60M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $2.39M | -64.5% |
| 2025 | Dec 31, 2025 | $6.73M | -8.5% |
| 2024 | Dec 31, 2024 | $7.36M | -64.8% |
| 2023 | Dec 29, 2023 | $20.91M | -64.0% |
| 2022 | Dec 30, 2022 | $58.13M | +30.2% |
| 2021 | Dec 31, 2021 | $44.66M | +91.5% |
| 2020 | Dec 31, 2020 | $23.32M | -3.6% |
| 2019 | Dec 31, 2019 | $24.19M | -44.3% |
| 2018 | Dec 31, 2018 | $43.40M | -40.8% |
| 2017 | Dec 29, 2017 | $73.30M | +351.1% |
| 2016 | Dec 30, 2016 | $16.25M | -4.7% |
| 2015 | Dec 31, 2015 | $17.06M | -75.6% |
| 2014 | Dec 31, 2014 | $69.78M | -79.7% |
| 2013 | Dec 31, 2013 | $343.12M | +80.1% |
| 2012 | Dec 31, 2012 | $190.47M | +6.2% |
| 2011 | Dec 30, 2011 | $179.30M | – |
See a number that looks wrong?